Differential regulation of the chemokine CCL21 in the antitumor immune response in non-small cell lung cancer

被引：0
|
作者：
Riutort-Garvi, Maria [1 ]
Delgado-Wicke, Pablo [2 ]
Cuesta-Mateos, Carlos [2 ]
Alfranca, Arantzazu [2 ]
机构：
[1] La Princesa Univ Hosp, Serv Immunol, Madrid, Spain
[2] Biomed Res Inst La Princesa Hosp IIS IP, Dept Immunol, Madrid, Spain
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2024年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
460 - P2.0
引用
收藏
页码：1075 / 1075
页数：1
相关论文
共 50 条
  • [1] Phase I trial CCL21 gene modified dendritic cells in non-small cell lung cancer
    Lee, J. M.
    Garon, E. B.
    Baratelli, F.
    Schaue, D.
    Pak, P. S.
    Wallace, W. D.
    Suh, R.
    Abtin, F.
    Zeng, G.
    Dubinett, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Characteristics of a CCL21 Gene-Modified Dendritic Cell Vaccine Utilized for a Clinical Trial in Non-Small Cell Lung Cancer
    Oh, Michael S.
    Dumitras, Camelia
    Salehi-Rad, Ramin
    Tran, Linh M.
    Krysan, Kostyantyn
    Lim, Raymond J.
    Jing, Zhe
    Tappuni, Shahed
    Lisberg, Aaron
    Garon, Edward B.
    Dubinett, Steven M.
    Liu, Bin
    MOLECULAR CANCER THERAPEUTICS, 2025, 24 (02) : 286 - 298
  • [3] CCL21/CCR7 Prevents Apoptosis via the ERK Pathway in Human Non-Small Cell Lung Cancer Cells
    Xu, Ying
    Liu, Lifeng
    Qiu, Xueshan
    Liu, Zihui
    Li, Haiying
    Li, Zixuan
    Luo, Wenting
    Wang, Enhua
    PLOS ONE, 2012, 7 (03):
  • [4] Immune-regulation of non-small cell lung cancer development
    Johansson, Magnus
    Beltran, Adam
    He, Biao
    Jablons, David
    Coussens, Lisa
    CANCER RESEARCH, 2009, 69
  • [5] Mechanism of CCL21/CCL19-CCR7 as a Key Regulatory Signaling Cassette for Non-Small Cell Lung Cancer Patients with Brain Metastasis
    Xiao, B.
    Li, J.
    Jiang, J. C.
    Zhang, B.
    Ding, H.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 84 : 79 - 85
  • [6] Alterations of immune response of non-small cell lung cancer with Azacytidine
    Wrangle, John
    Wang, Wei
    Koch, Alexander
    Easwaran, Hariharan
    Mohammad, Helai P.
    Vendetti, Frank
    VanCriekinge, Wim
    De Meyer, Tim
    Du, Zhengzong
    Parsana, Princy
    Rodgers, Kristen
    Yen, Ray-Whay
    Zahnow, Cynthia A.
    Taube, Janis M.
    Brahmer, Julie R.
    Tykodi, Scott S.
    Easton, Keith
    Carvajal, Richard D.
    Jones, Peter A.
    Laird, Peter W.
    Weisenberger, Daniel J.
    Tsai, Salina
    Juergens, Rosalyn A.
    Topalian, Suzanne L.
    Rudin, Charles M.
    Brock, Malcolm V.
    Pardoll, Drew
    Baylin, Stephen B.
    ONCOTARGET, 2013, 4 (11) : 2067 - 2079
  • [7] Neoadjuvant chemotherapy influence changes of the immune response in non-small cell lung carcinomas immune response in non-small cell lung carcinomas
    Cuentas, Edwin Roger
    Behrens, Carmen
    Rodriguez-Canales, Jaime
    Jiang, Mei
    Pataer, Apar
    Correa, Arelene
    Swisher, Stephen
    Sepesi, Boris
    Weissferdt, Annikka
    Kalhor, Neda
    Zhang, Jiexin
    Lee, Jack
    Heymach, John
    Moran, Cesar
    Zhang, Jianjun
    Gibbons, Don
    Wistuba, Ignacio
    CANCER RESEARCH, 2017, 77
  • [8] CCL21 promotes the migration and adhesion of highly lymph node metastatic human non-small cell lung cancer Lu-99 in vitro
    Koizumi, Keiichi
    Kozawa, Yoko
    Ohashi, Yasukata
    Nakamura, Eliane Shizuka
    Aozuka, Yasushi
    Sakurai, Hiroaki
    Ichiki, Katsuyuki
    Doki, Yoshinori
    Misaki, Takuro
    Saiki, Ikuo
    ONCOLOGY REPORTS, 2007, 17 (06) : 1511 - 1516
  • [9] Prognostic Immune Markers in Non-Small Cell Lung Cancer-Response
    Suzuki, Kei
    Adusumilli, Prasad S.
    CLINICAL CANCER RESEARCH, 2011, 17 (24) : 7836 - 7836
  • [10] Immune Signatures of Non-Small Cell Lung Cancer
    Green, Susan
    Dawe, David E.
    Banerji, Shantanu
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (06) : 913 - 915
12345